Plasmid DNA encapsulation and release from solvent diffusion nanospheres

Journal of Controlled Release

Volumn 70, Issue 1-2, 2001, Pages 231-242

  Hirosue, S ^a,b   Muller B G ^c   Mulligan, R C ^c   Langer, R ^a,c  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

Controlled release; DNA encapsulation; Nanospheres; Plasmid DNA; Solvent diffusion

Indexed keywords

CATION; DENDRIMER; DIMETHYLDIOCTADECYLAMMONIUM BROMIDE; EXCIPIENT; LIPID; NANOPARTICLE; PEPTIDE; PLASMID DNA; POLYGLACTIN; POLYLYSINE; POLYMER; PROTEIN; SOLVENT; SPERMIDINE; SPERMINE; STARBURST; TRIMETHYLAMMONIUM SALT DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED DRUG RELEASE; DIFFUSION; ENCAPSULATION; GENE TARGETING; HYDROPHILICITY; HYDROPHOBICITY; PH; PRIORITY JOURNAL; SURFACE CHARGE;

DIFFUSION; DNA; EXCIPIENTS; GENE THERAPY; LACTIC ACID; PARTICLE SIZE; PLASMIDS; POLYGLYCOLIC ACID; POLYMERS;

EID: 0035966495     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(00)00353-9     Document Type: Article

References (50)

1. Synthetic DNA delivery systems
2. Preparation and characterization of poly (D,L-lactide-co-glycolide) microspheres for controlled release of poly(L-lysine) complexed plasmid DNA
3. Encapsulation of plasmid DNA in biodegradable poly(D,L-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery
4. Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses
5. PLGA microspheres containing plasmid DNA: Preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization
6. Influence of formulation parameters on the characteristics of poly(D,L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA
7. Controlled DNA delivery systems
8. Controlled release of plasmid DNA
9. Microencapsulation of DNA using poly(DL-lactide-co-glycolide): Stability issues and release characteristics
10. Biologically erodable microspheres as potential oral drug delivery systems
11. Taking polycation gene delivery systems from in vitro to in vivo
12. DNA-polycation nanospheres as non-viral gene delivery vehicles
13. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy
14. Controlled gene delivery by DNA-gelatin nanospheres
15. Gene transfer by DNA-gelatin nanospheres
16. Use of liposomes, viral capsids, and nanoparticles as DNA carriers
17. Polyalkylcyanoacrylate nanoparticles as polymer carriers for antisense oligonucleotides
18. Antisense effects of cholesterol-oligonucleotide conjugates associated with poly (alkylcyanoacrylate) nanoparticles
19. Nanoparticle DNA carrier with poly(L-lysine) grafted polysaccharide copolymer and poly(D,L-lactic acid)
20. Adsorption of oligonucleotides onto polyisohexyl cyanoacrylate nanoparticles protects them against nucleases and increases their cellular uptake
21. Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers
22. PLGA nanoparticles prepared by nanoprecipitation: Drug loading and release studies of a water soluble drug
23. Properties of a peptide containing DL-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods
24. Pulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect
25. Preparations of biodegradable nanospheres of water soluble and insoluble drugs with dl-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior
26. In vitro drug release behavior of D,L-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate prepared by a novel spontaneous emulsification solvent diffusion method
27. Biodegradable submicron carriers for peptide drugs: Preparation of DL-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate by a novel emulsion-phase separation method in an oil system
28. Biodegradation and biocompatibility of PLA and PLGA microspheres
29. Biodegradable polymers for use in surgery - Polyglycolic/poly (lactic acid) homo- and copolymers: 1
30. Trifluoroethanol and colleagues: Cosolvents come of age. Recent studies with peptides and proteins
31. Pharmaceutical approach to somatic gene therapy
32. Cationic microparticles: A potent delivery system for DNA vaccines
33. Mechanism of sustained-action medication: Theoretical analysis of rate of release of solid drugs dispersed in solid matrices
34. A theoretical model of erosion and macromolecular drug release from biodegrading microspheres
35. Degradation of poly(lactic-co-glycolic acid) microspheres: Effect of copolymer composition
36. Factors affecting the in vitro release of recombinant human interferon-gamma (rhIFN-γ) from PLGA microspheres
37. Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells
38. Major limitations in the use of cationic liposomes for DNA delivery
39. 2,2,2-Trifluoroethanol intestinal and bone marrow toxicity: The role of its metabolism to 2,2,2-trifluoroacetaldehyde and trifluoroacetic acid
40. 19F nuclear magnetic resonance analysis of trifluoroethanol metabolites in the urine of the Sprague-Dawley rat
41. Transfection of myoblasts in primary culture with isomeric cationic cholesterol derivatives
42. Gene-delivery systems using cationic polymers
43. Systemic gene-expression after intravenous DNA delivery into adult mice
44. Interactions of cationic lipid vesicles with negatively charged phospholipid vesicles and biological membranes
45. Gene delivery mediated by cationic liposomes: From biophysical aspects to enhancement of transfection
46. Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers